Hyoscine Butyl Bromide for Management of Prolonged Labor

• Status: Unknown status
• Trial end date: 2017-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

To determine the value of using Hyoscine as an antispasmodic drug for the management of prolonged labor in nulliparous women at term.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Collaborators: Armed Forces Hospital, Southern Region, Khamis Mushayt, Saudi Arabia; Armed Forces Hospitals, Southern Region, Saudi Arabia
• Treatments: Bromides; Butylscopolammonium Bromide; Scopolamine; Scopolamine Hydrobromide

Criteria

Inclusion Criteria:

• Nulliparous women.

• Prolonged labor defined as no progress of labor for 2 hours or more.

• Gestational age ≥ 37 weeks.

• Singleton pregnancy.

• Cephalic presentation.

• Cervical dilatation ≥ 5 cm.

• Intact fetal membranes.

• No evidence of maternal or fetal distress.

• Average size baby.

Exclusion Criteria:

• Multigravid women.

• Multifetal pregnancy.

• History of cervical surgery.

• Blood pressure > 150/90 mmHg.

• Mal-presentation and mal-positions.

• Hypersensitivity to Hyoscine.

• Contraindication for vaginal delivery.